Design, synthesis, and characterization of 3-(2-(pyrimidin-5-yl)thiazol-4-yl)-1,2,4-oxadiazole derivatives: Anticancer and molecular docking investigations

References

• Hemming, K. 1,2,4-Oxadiazoles. In Comprehensive Heterocyclic Chemistry III; Alan, R. K., Christopher, A. R., Eric, F. V. S., Richard, J. K. T., Eds.; Elsevier: Oxford, 2008; pp 243–314.
   Google Scholar
• Boys, M.; Schretzman, L.; Chandrakumar, N.; Tollefson, M.; Mohler, S.; Downs, V.; Penning, T.; Russell, M.; Wendt, J.; Chen, B.; et al. Convergent, Parallel Synthesis of a Series of β-Substituted 1,2,4-Oxadiazole Butanoic Acids as Potent and Selective αvβ3 Receptor Antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 839–844. DOI: 10.1016/j.bmcl.2005.11.008.
   PubMed Web of Science ®Google Scholar
• Clitherow, J. W.; Beswick, P.; Irving, W. J.; Scopes, D. I. C.; Barnes, J. C.; Clapham, J.; Brown, J. D.; Evans, D. J.; Hayes, A. G. Novel 1, 2, 4-Oxadiazoles as Potent and Selective Histamine H3 Receptor Antagonists. Bioorg. Med. Chem. Lett. 1996, 6, 833–838. DOI: 10.1016/0960-894X(96)00122-9.
   Web of Science ®Google Scholar
• Kiss, L. E.; Ferreira, H. S.; Torrao, L.; Bonifacio, M. J.; Palma, P. N.; Soares-da-Silva, P.; Learmonth, D. A. Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-Methyltransferase. J. Med. Chem. 2010, 53, 3396–3411. DOI: 10.1021/jm1001524.
   PubMed Web of Science ®Google Scholar
• Ispikoudi, M.; Amvrazis, M.; Kontogiorgis, C.; Koumbis, A. E.; Litinas, K. E.; Hadjipavlou-Litina, D.; Fylaktakidou, K. C. Convenient Synthesis and Biological Profile of 5-Amino-Substituted 1,2,4-Oxadiazole Derivatives. Eur. J. Med. Chem. 2010, 45, 5635–5645. DOI: 10.1016/j.ejmech.2010.09.016.
   PubMed Web of Science ®Google Scholar
• Jeschke, P.; Wachendorff-Neumann, U.; Erdelen, C.; Mencke, N.; Turberg, A. Ger. Offen. DE 4; 401,107 (Cl.C07D271/06), 20 Jul 1995, Appl. 17 Jan 1994, 40pp. Chem. Abstr. 1995, 123, 340135t.
   Google Scholar
• dos Santos Filho, J. M.; Leite, A. C. L.; de Oliveira, B. G.; Moreira, D. R. M.; Lima, M. S.; Soares, M. B. P.; Leite, L. F. C. C. Design, Synthesis and Cruzain Docking of 3-(4-Substituted-Aryl)-1,2,4-oxadiazole-N-Acylhydrazones as anti-Trypanosoma cruzi Agents. Bioorg. Med. Chem. 2009, 17, 6682–6691. DOI: 10.1016/j.bmc.2009.07.068.
   PubMed Web of Science ®Google Scholar
• Manfredini, S.; Lampronti, I.; Vertuani, S.; Solaroli, N.; Recanatini, M.; Bryan, D.; McKinney, M. Design, Synthesis and Binding at Cloned Muscarinic Receptors of N-[5-(1′-Substituted-Acetoxymethyl)-3-Oxadiazolyl] and N-[4-(1′-Substituted-Acetoxymethyl)-2-Dioxolanyl] Dialkyl Amines. Bioorg. Med. Chem. 2000, 8, 1559–1566. DOI: 10.1016/s0968-0896(00)00092-4.
   PubMed Web of Science ®Google Scholar
• Bokach, N. A.; Khripoun, A. V.; Kukushkin, V. Y.; Haukka, M.; Pombeiro, A. J. L. A Route to 1,2,4-Oxadiazoles and Their Complexes via Platinum-Mediated 1,3-Dipolar Cycloaddition of Nitrile Oxides to Organonitriles. Inorg. Chem. 2003, 42, 896–903. DOI: 10.1021/ic026103v.
   PubMed Web of Science ®Google Scholar
• Cottrell, D. M.; Capers, J.; Salem, M. M.; DeLuca-Fradley, K.; Croft, S. L.; Werbovetz, K. A. Antikinetoplastid Activity of 3-Aryl-5-Thiocyanatomethyl-1,2,4-Oxadiazoles. Bioorg. Med. Chem. 2004, 12, 2815–2824. DOI: 10.1016/j.bmc.2004.03.054.
   PubMed Web of Science ®Google Scholar
• Haugwitz, R. D.; Martinez, A. J.; Venslavsky, J.; Angel, R. G.; Maurer, B. V.; Jacobs, G. A.; Narayanan, V. L.; Cruthers, L. R.; Szanto, J. Antiparasitic Agents. 6. Synthesis and Anthelmintic Activities of Novel Isothiocyanatophenyl-1,2,4-Oxadiazoles. J. Med. Chem. 1985, 28, 1234–1241. DOI: 10.1021/jm00147a019.
   PubMed Web of Science ®Google Scholar
• Xu, J.; Wei, L.; Mathvink, R.; He, J.; Park, Y. J.; He, H.; Leiting, B.; Lyons, K. A.; Marsilio, F.; Patel, R. A.; et al. Discovery of Potent and Selective Phenylalanine Based Dipeptidyl Peptidase IV Inhibitors. Bioorg. Med. Chem. Lett. 2005, 15, 2533–2536. DOI: 10.1016/j.bmcl.2005.03.055.
   PubMed Web of Science ®Google Scholar
• Antunes, R.; Batista, H.; Srivastava, R. M.; Thomas, G.; Araujo, C. C.; Longo, R. L.; Magalhaes, H.; Leao, M. B. C.; Pava, A. C. Synthesis, Characterization and Interaction Mechanism of New Oxadiazolo-Phthalimides as Peripheral Analgesics. IV. J. Mol. Struct. 2003, 660, 1–13. DOI: 10.1016/S0022-2860(03)00418-6.
   Web of Science ®Google Scholar
• Lueg, C.; Schepmann, D.; Günther, R.; Brust, P.; Wünsch, B. Development of Fluorinated CB2 Receptor Agonists for PET Studies. Bioorg. Med. Chem. 2013, 21, 7481–7498. DOI: 10.1016/j.bmc.2013.09.040.
   PubMedGoogle Scholar
• Axel, K.; Jürgen, E. Pharmaceutical Substances: Syntheses, Patents, Applications; Thieme Chemistry, Stuttgart, Germany, 2001.
   Google Scholar
• Sonia, Z. H.; Jaya, D.; Kishore, D.; Aleksey, E. K. Synthesis, Characterization, and DFT Study of the s-Triazine Analogues of Medicinal Interest Incorporated with Five- and Six-Membered Bioactive Heterocyclic Scaffolds. J. Mol. Struct. 2023, 1278, 134922. DOI: 10.1016/j.molstruc.2023.134922.
   Web of Science ®Google Scholar
• Sonia, Z. H.; Kishore, D. Design, Synthesis and Characterization of [1,3,4]-Thiadiazolo- and [1,2,4]-Oxadiazolo Substituted 2,4-Dicyclopropylamino-6- Phenoxy-s-Triazines. Arkivoc. 2016, 2016, 318–326. DOI: 10.3998/ark.5550190.p009.678.
   Google Scholar
• Hashmi, S. Z.; Kishore, D. Novel Synthesis of Imidazo-Based and Benzimidazo-Based Privileged Templates on s-Triazine Nucleus through a Phenoxyl Spacer. J. Heterocycl. Chem. 2017, 00, 00.
   Google Scholar
• EL-Gazzar, A. B. A.; Hussein, H. A. R.; Hafez, H. N. Synthesis and Biological Evaluation of Thieno[2,3-d]Pyrimidine Derivatives for anti-Inflammatory, Analgesic and Ulcerogenic Activity. Acta Pharm. 2007, 57, 395–411. DOI: 10.2478/v10007-007-0032-6.
   PubMedGoogle Scholar
• Nag, S.; Pathak, R.; Kumar, M.; Shukla, P. K.; Batra, S. Synthesis and Antibacterial Evaluation of Ureides of Baylis–Hillman Derivatives. Bioorg. Med. Chem. Lett. 2006, 16, 3824–3828. DOI: 10.1016/j.bmcl.2006.04.020.
   PubMed Web of Science ®Google Scholar
• Agarwal, A.; Srivastava, K.; Puri, S. K.; Chauhan, P. M. S. Synthesis of 2,4,6-Trisubstituted Pyrimidines as Antimalarial Agents. Bioorg. Med. Chem. 2005, 13, 4645–4650. DOI: 10.1016/j.bmc.2005.04.061.
   PubMed Web of Science ®Google Scholar
• Majeed, J.; Shaharyar, M. Synthesis and in Vivo Diuretic Activity of Some Novel Pyrimidine Derivatives. J. Enzyme Inhib. Med. Chem. 2011, 26, 819–826. DOI: 10.3109/14756366.2011.557022.
   PubMed Web of Science ®Google Scholar
• Trivedi, A. R.; Dodiya, D. K.; Ravat, N. R.; Shah, V. H. Synthesis and Biological Evaluation of Some New Pyrimidines via a Novel Chalcone Series. ARKIVOC. 2008, 2008, 131–141. DOI: 10.3998/ark.5550190.0009.b13.
   Google Scholar
• Jain, K. S.; Chitre, T. S.; Miniyar, P. B.; Kathiravan, M. K.; Bendre, V. S.; Veer, V. S.; Shahane.; S. R.; Shishoo. Biological and Medicinal Significance of Pyrimidines. J. Curr. Sci. 2006, 90, 793–803.
   Google Scholar
• Padmaja, A.; Payani, T.; Reddy, G. D.; Padmavathi, V. Synthesis, Antimicrobial and Antioxidant Activities of Substituted Pyrazoles, Isoxazoles, Pyrimidine and Thioxopyrimidine Derivatives. Eur. J. Med. Chem. 2009, 44, 4557–4566. DOI: 10.1016/j.ejmech.2009.06.024.
   PubMed Web of Science ®Google Scholar
• Hoffmann, H. H.; Kunz, A.; Simon, V. A.; Palese, P.; Shaw, M. L. Broad-Spectrum Antiviral That Interferes with de Novo Pyrimidine Biosynthesis. Proc. Natl. Acad. Sci. USA. 2011, 108, 5777–5782. DOI: 10.1073/pnas.1101143108.
   PubMed Web of Science ®Google Scholar
• Morris, G. W.; Iams, T. A.; Slepchenko, K. G.; McKee, E. E. Origin of Pyrimidine Deoxyribonucleotide Pools in Perfused Rat Heart: implications for 3′-Azido-3′-Deoxythymidine-Dependent Cardiotoxicity. Biochem. J. 2009, 422, 513–520. DOI: 10.1042/BJ20082427.
   PubMed Web of Science ®Google Scholar
• Xie, F.; Zhao, H.; Zhao, L.; Lou, L.; Hu, Y. Synthesis and Biological Evaluation of Novel 2,4,5-Substituted Pyrimidine Derivatives for Anticancer Activity. Bioorg. Med. Chem. Lett. 2009, 19, 275–278. DOI: 10.1016/j.bmcl.2008.09.067.
   PubMed Web of Science ®Google Scholar
• Janne, P. A.; Yang, J. C. H.; Kim, D. W.; Planchard, D.; Ohe, Y.; Ramalingam, S. S.; Ahn, M. J.; Kim, S. W.; Su, W. C.; Horn, L.; et al. ZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer. N Engl. J. Med. 2015, 372, 1689–1699. DOI: 10.1056/NEJMoa1411817.
   PubMed Web of Science ®Google Scholar
• Gfeller, D.; Michielin, O.; Zoete, V. Shaping the Interaction Landscape of Bioactive Molecules. Bioinformatics. 2013, 29, 3073–3079. DOI: 10.1093/bioinformatics/btt540.
   PubMed Web of Science ®Google Scholar
• Lagunin, A. A.; Dubovskaja, V. I.; Rudik, A. V.; Pogodin, P. V.; Druzhilovskiy, D. S.; Gloriozova, T. A.; Filimonov, D. A.; Sastry, N. G.; Poroikov, V. V. CLC-Pred: A Freely Available Web-Service for in Silico Prediction of Human Cell Line Cytotoxicity for Drug-like Compounds. PLOS One. 2018, 13, e0191838. DOI: 10.1371/journal.pone.0191838.
   PubMed Web of Science ®Google Scholar
• Masoud, V.; Pagès, G. Targeted Therapies in Breast Cancer: New Challenges to Fight against Resistance. World J. Clin. Oncol. 2017, 8, 120–134. DOI: 10.5306/wjco.v8.i2.120.
   PubMed Web of Science ®Google Scholar
• Wood, E. R.; Truesdale, A. T.; McDonald, O. B.; Yuan, D.; Hassell, A.; Dickerson, S. H.; Ellis, B.; Pennisi, C.; Horne, E.; Lackey, K.; et al. A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) Relationships among Protein Conformation, Inhibitor off-Rate, and Receptor Activity in Tumor Cells. Cancer Res. 2004, 64, 6652–6659. DOI: 10.1158/0008-5472.CAN-04-1168.
   PubMed Web of Science ®Google Scholar
• Qiu, C.; Tarrant, M. K.; Choi, S. H.; Sathyamurthy, A.; Bose, R.; Banjade, S.; Pal, A.; Bornmann, W. G.; Lemmon, M. A.; Cole, P. A.; Leahy, D. J. Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase. Structure. 2008, 16, 460–467. DOI: 10.1016/j.str.2007.12.016.
   PubMed Web of Science ®Google Scholar
• Sander, T.; Freyss, J.; von Korff, M.; Rufener, C. DataWarrior: An Open-Source Program for Chemistry Aware Data Visualization and Analysis. J. Chem. Inf. Model. 2015, 55, 460–473. DOI: 10.1021/ci500588j.
   PubMed Web of Science ®Google Scholar
• Morris, G. M.; Goodsell, D. S.; Huey, R.; Hart, W. E.; Halliday, S.; Belew, R.; Olson, A. J. AutoDock. Automated Docking of Flexible Ligands to Receptor-User Guide, J. Comput. Chem., 30(16), 3785-3791, 2009. DOI: 10.1002/jcc.21256.
   Google Scholar